APTALIS PHARMATECH INC | AbbVie | Ohio | state | 2013 | $25,390 | | training reimbursement |
Anda Pharmaceuticals, Inc. | AbbVie | Ohio | state | 2001 | undisclosed | | tax credit/rebate |
Forest Laboratories, Inc. | AbbVie | New York | local | 2012 | $30,451 | | tax credit/rebate; property tax abatement |
APTALIS PHARMATECH INC | AbbVie | Ohio | state | 2014 | $159,943 | | grant |
Forest Research Institute, Inc. | AbbVie | Pennsylvania | state | 2013 | $369,915 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. (f/k/a Concurrent Pharmaceuticals, Inc.) | AbbVie | Pennsylvania | state | 2013 | $36,899 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | North Carolina | state | 2013 | $8,044 | | tax credit/rebate |
Furiex Pharmaceuticals, Inc. | AbbVie | North Carolina | state | 2013 | $4,011 | | tax credit/rebate |
Durata Therapeutics, Inc. | AbbVie | Connecticut | state | 2013 | $8,000 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2013 | $2,677 | | tax credit/rebate; property tax abatement |
Forest Laboratories, Inc. | AbbVie | New York | local | 2013 | $3,462 | | tax credit/rebate; property tax abatement |
Forest Research Institute, Inc. | AbbVie | North Carolina | state | 2014 | $5,583 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. (f/k/a Concurrent Pharmaceuticals, Inc.) | AbbVie | Pennsylvania | state | 2014 | $83,843 | | tax credit/rebate |
ALLERGAN INC | AbbVie | California | state | 2015 | $325,700 | | training reimbursement |
Forest Laboratories, Inc. | AbbVie | New York | local | 2014 | $90,408 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2014 | $3,933 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2015 | $80,382 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | North Carolina | state | 2015 | $3,513 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2015 | $3,976 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2015 | $641,296 | | tax credit/rebate |
Allergan Sales, LLC | AbbVie | New Jersey | state | 2016 | $58,284,000 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2016 | $269,391 | | tax credit/rebate |
Allergan Sales, LLC | AbbVie | New Jersey | state | 2016 | $58,284,000 | | MEGADEAL (Archived) |
Steel Forest, LLC | AbbVie | New York | local | 2016 | $254,454 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2016 | $3,912 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2017 | $726,780 | | tax credit/rebate |
AbbVie Inc. | AbbVie | Massachusetts | state | 2016 | $525,000 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2017 | $275,871 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2017 | $3,885 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2019 | $180,014 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2018 | $83,752 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2018 | $39,409 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2019 | $39,219 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | Local | 2018 | $206,943 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2019 | $1,159 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2020 | $39,219 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2020 | $180,014 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $47,739 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $110,366 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $302,558 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $581,555 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2020 | $326,753 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2021 | $261,116 | | tax credit/rebate |
Allergan Sales, LLC | AbbVie | North Carolina | state | 2017 | $232,175 | | tax credit/rebate |
Allergan Inc. | AbbVie | Texas | local | 2012 | undisclosed | | grant |
Steel Forest, LLC | AbbVie | New York | local | 2022 | $264,555 | | tax credit/rebate |
Aclaris Therapeutics, Inc. | Aclaris Therapeutics | Pennsylvania | state | 2014 | $20,248 | | tax credit/rebate |
Aclaris Therapeutics, Inc. | Aclaris Therapeutics | Pennsylvania | state | 2015 | $12,925 | | tax credit/rebate |
Aclaris Therapeutics, Inc. | Aclaris Therapeutics | Pennsylvania | state | 2016 | $24,916 | | tax credit/rebate |
Aclaris Therapeutics, Inc. | Aclaris Therapeutics | Pennsylvania | state | 2016 | $24,916 | | tax credit/rebate |
Aclaris Therapeutics, Inc. | Aclaris Therapeutics | Pennsylvania | state | 2017 | $93,554 | | tax credit/rebate |
Acorda Therapeutics, Inc. | Acorda Therapeutics | New York | local | 2011 | $74,668 | | tax credit/rebate; property tax abatement |
Acorda Therapeutics, Inc. | Acorda Therapeutics | New York | local | 2012 | $666,023 | | tax credit/rebate; property tax abatement |
Acorda Therapeutics, Inc. | Acorda Therapeutics | New York | local | 2013 | $6,017 | | tax credit/rebate; property tax abatement |
Acorda Therapeutics | Acorda Therapeutics | New York | state | 2015 | $5,209,220 | | tax credit/rebate |
Acorda Therapeutics, Inc. | Acorda Therapeutics | New York | local | 2014 | $114,848 | | tax credit/rebate |
Acorda Therapeutics, Inc. | Acorda Therapeutics | New York | local | 2015 | $37,464 | | tax credit/rebate |
Acorda Therapeutics, Inc. | Acorda Therapeutics | Massachusetts | state | 2017 | $495,000 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2012 | $5,319 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2014 | $8,340 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2015 | $3,448 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2016 | $22,708 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2018 | $9,300 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2017 | $32,567 | | tax credit/rebate |
HI TECH Pharmacal Company | Akorn Inc. | United States | federal | 2012 | $603,688 | | federal grant |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2008 | $1,274,849 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2008 | $1,274,849 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2008 | $1,274,849 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2009 | $453,858 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2009 | $453,858 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2009 | $453,858 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2010 | $753,841 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2010 | $753,841 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2010 | $753,841 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2011 | $698,828 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2011 | $698,828 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2011 | $698,828 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2012 | $92,277 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2012 | $92,277 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2012 | $92,277 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2013 | $512,604 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2013 | $512,604 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2013 | $512,604 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2014 | $1,257,792 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2014 | $1,257,792 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2014 | $1,257,792 | | enterprise zone |
Akorn, Inc. | Akorn Inc. | Illinois | state | 2015 | $596,900 | | tax credit/rebate |
Cambridge Major Laboratories, Inc. | Alcami | Wisconsin | state | 2011 | $300,000 | | tax credit/rebate |
Cambridge Major Laboratories, Inc. | Alcami | Wisconsin | state | 2014 | $800,000 | | tax credit/rebate |
AAIPharma Services Corp. | Alcami | North Carolina | state | 2013 | $27,212 | | tax credit/rebate |
AAIPharma Services Corp. | Alcami | North Carolina | state | 2014 | $19,526 | | tax credit/rebate |
AAIPharma Services Corp. | Alcami | North Carolina | state | 2015 | $27,431 | | tax credit/rebate |
Alcami Carolinas Corporation | Alcami | North Carolina | state | 2016 | $54,466 | | tax credit/rebate |
Alcami Carolinas Corporation | Alcami | North Carolina | state | 2017 | $35,605 | | tax credit/rebate |
Alcami Carolinas Corporation | Alcami | South Carolina | state | 2022 | undisclosed | | grant |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | | $50,000 | | grant |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2012 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2011 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2010 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2013 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2014 | $100,000 | | tax credit/rebate |